HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Merkel Cell Carcinoma

Merkel cell carcinoma (MCC) is a rare and aggressive form of skin cancer that arises from Merkel cells, which are found in the skin's top layer. Merkel cells are responsible for the sense of touch. Although Merkel cell carcinoma is uncommon, its incidence has been steadily increasing. This type of skin cancer typically appears as firm, painless nodules or lumps on the skin, often red or purple in color. MCC most commonly affects sun-exposed areas of the body, such as the head and neck. The exact cause of Merkel cell carcinoma is not fully understood, but it is strongly linked to exposure to ultraviolet (UV) radiation from the sun and other sources. One of the distinguishing features of Merkel cell carcinoma is its potential to spread quickly to nearby lymph nodes and other organs, making early detection crucial. Diagnosis often involves a biopsy of the suspicious lesion. Treatment options for Merkel cell carcinoma may include surgery, radiation therapy, and, in some cases, immunotherapy. Due to its rarity and aggressive nature, managing Merkel cell carcinoma requires a multidisciplinary approach involving dermatologists, oncologists, and other healthcare professionals. Regular skin examinations and sun protection measures, such as wearing sunscreen and protective clothing, are essential for individuals at risk or with a history of skin cancer. Despite ongoing research efforts, Merkel cell carcinoma poses significant challenges due to its unpredictable behavior and limited treatment options. As with any cancer, early detection and prompt medical intervention are crucial factors in improving outcomes for individuals diagnosed with Merkel cell carcinoma.

Committee Members
Speaker at International Cancer Conference 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Cancer Conference 2026 - Patricia Tai

Patricia Tai

UpToDate, Canada
Speaker at International Cancer Conference 2026 - Jose Manuel Cervera Grau

Jose Manuel Cervera Grau

Preclinical Lab and Computational Drug Discovery Program, Relayer Biotech Inc, Spain

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp